Patterns of long-term survivorship following bevacizumab treatment for recurrent glioma: a case series
Aim: Long-term survivors (LTS) after glioma recurrence while on bevacizumab (Bev) therapy are rarely reported in the current literature. The purpose of this case series is to confirm the existence of and describe a large cohort of recurrent glioma LTS treated with Bev (Bev-LTS). Patients & metho...
Main Authors: | Liang Yen Liu, Matthew S Ji, Nhung T Nguyen, Frances E Chow, Donna M Molaie, Sean T Pianka, Richard M Green, Linda M Liau, Benjamin M Ellingson, Phioanh L Nghiemphu, Timothy F Cloughesy, Albert Lai |
---|---|
פורמט: | Article |
שפה: | English |
יצא לאור: |
Taylor & Francis Group
2019-06-01
|
סדרה: | CNS Oncology |
נושאים: | |
גישה מקוונת: | https://www.futuremedicine.com/doi/10.2217/cns-2019-0007 |
פריטים דומים
-
Radiographic patterns of recurrence and pathologic correlation in malignant gliomas treated with bevacizumab
מאת: Alissa Thomas, et al.
יצא לאור: (2018-01-01) -
A validated microRNA profile with predictive potential in glioblastoma patients treated with bevacizumab
מאת: Josie Hayes, et al.
יצא לאור: (2016-10-01) -
A contemporary perspective on the diagnosis and treatment of diffuse gliomas in adults
מאת: Patrick Roth, et al.
יצא לאור: (2020-06-01) -
Dose and Efficacy of Bevacizumab in Recurrent High-Grade Gliomas: A Retrospective Study
מאת: Bai X, et al.
יצא לאור: (2024-11-01) -
Bevacizumab in recurrent WHO grades II–III glioma
מאת: Soufyan Annakib, et al.
יצא לאור: (2023-07-01)